PM

Prosight Management Portfolio holdings

AUM $410M
1-Year Est. Return 14.96%
This Quarter Est. Return
1 Year Est. Return
-14.96%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$304M
AUM Growth
-$52.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
41
New
Increased
Reduced
Closed

Top Buys

1
+$9.72M
2
+$8.11M
3
+$7.28M
4
TECX
Tectonic Therapeutic
TECX
+$7.06M
5
ISRG icon
Intuitive Surgical
ISRG
+$6.93M

Top Sells

1
+$13.3M
2
+$12.2M
3
+$10.1M
4
ZBH icon
Zimmer Biomet
ZBH
+$8.45M
5
SDGR icon
Schrodinger
SDGR
+$6.62M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRBP icon
26
Corbus Pharmaceuticals
CRBP
$224M
$3.05M 1%
575,136
+305,136
CTMX icon
27
CytomX Therapeutics
CTMX
$526M
$2.5M 0.82%
3,930,008
+25,008
CDNA icon
28
CareDx
CDNA
$779M
$2.42M 0.8%
136,593
+56,593
BHVN icon
29
Biohaven
BHVN
$1.69B
$2.4M 0.79%
+100,000
ADUS icon
30
Addus HomeCare
ADUS
$2.17B
$2.38M 0.78%
+24,045
SGHT icon
31
Sight Sciences
SGHT
$229M
$2.33M 0.76%
969,287
+60,440
ERAS icon
32
Erasca
ERAS
$678M
$1.3M 0.43%
947,110
SYRE icon
33
Spyre Therapeutics
SYRE
$1.71B
$1.21M 0.4%
74,921
-5,079
OKUR
34
OnKure Therapeutics
OKUR
$38.2M
$802K 0.26%
186,570
+122,816
RNTX
35
Rein Therapeutics
RNTX
$29.3M
$761K 0.25%
430,000
+25,021
MURA icon
36
Mural Oncology
MURA
$35.9M
$533K 0.18%
422,743
-44,079
PLRX icon
37
Pliant Therapeutics
PLRX
$98.2M
$451K 0.15%
+334,263
IMNM icon
38
Immunome
IMNM
$1.37B
$159K 0.05%
23,618
-30,724
CNC icon
39
Centene
CNC
$17.4B
– –
-55,000
FTRE icon
40
Fortrea Holdings
FTRE
$828M
– –
-55,100
ZBH icon
41
Zimmer Biomet
ZBH
$20B
– –
-80,000
1
2